1. Home
  2. BOTJ vs KLRS Comparison

BOTJ vs KLRS Comparison

Compare BOTJ & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of the James Financial Group Inc.

BOTJ

Bank of the James Financial Group Inc.

HOLD

Current Price

$22.85

Market Cap

106.0M

Sector

Finance

ML Signal

HOLD

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

HOLD

Current Price

$4.94

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOTJ
KLRS
Founded
1998
2019
Country
United States
United States
Employees
N/A
20
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.0M
116.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BOTJ
KLRS
Price
$22.85
$4.94
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.00
AVG Volume (30 Days)
11.0K
82.7K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
1.92%
N/A
EPS Growth
13.71
N/A
EPS
0.61
N/A
Revenue
$4,273,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.62
N/A
Revenue Growth
6.74
N/A
52 Week Low
$13.03
$2.14
52 Week High
$23.71
$11.88

Technical Indicators

Market Signals
Indicator
BOTJ
KLRS
Relative Strength Index (RSI) 51.13 40.90
Support Level $20.18 $4.35
Resistance Level $23.71 $5.38
Average True Range (ATR) 0.41 0.37
MACD -0.12 0.06
Stochastic Oscillator 24.56 38.18

Price Performance

Historical Comparison
BOTJ
KLRS

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: